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(57) ABSTRACT
Novel reporter bacteriophages are provided. Provided are
compositions and methods that allow bacteriophages that are
used for specific detection or killing of E. coli 0157:H7 to be
propagated in nonpathogenic E. coli, thereby eliminating the
safety and security risks of propagation in E. coli 0157:H7.
Provided are compositions and methods for attaching active
bacteriophages to the surface of a polymer in order to kill
target bacteria with which the phage comes into contact.
Provided are modified bacteriophages immobilized to a sur-
face, which capture E. coli 0157:H7 and cause the captured
cells to emit light or fluorescence, allowing detection of the
bacteria in a sample.
12 Claims, 4 Drawing Sheets
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METHODS FOR GENERATION OF
REPORTER PHAGES AND
IMMOBILIZATION OF ACTIVE
BACTERIOPHAGES ON A POLYMER
SURFACE
RELATED APPLICATIONS
This application claims the benefit of U.S. Provisional
Application Ser. No. 61/093,004, filed Aug. 29, 2008, the
entire contents of which is hereby incorporated by reference.
GOVERNMENT INTERESTS
This invention was made with United States government
support, specifically, Grant No. 58-1935-4-430, awarded by
the USDA and Grant No. NAGS-12686, awarded by NASA.
The United States government may have certain rights in this
invention.
FIELD OF THE DISCLOSURE
This application relates to the fields of genetic engineering,
molecular biology, and microbiology. In particular, thi s appli-
cation relates to the use of bacteriophages in assays and
processes.
BACKGROUND
Bacteriophages are viruses that infect bacteria. Bacte-
riophages, also called phages, may have a lysogenic cycle or
a lytic cycle. Lysogenic phages are phages that can enter one
of two alternative paths when infecting a cell: their DNA can
integrate into the host DNA and replicate along with it, cre-
ating a lysogen; or the lytic cycle can occur instead. In the
lytic cycle, once the phage has infected a bacterial cell, many
copies of phage DNA are made, followed by synthesis of
many phage capsids. The DNA is packaged in the capsids, the
cell is lysed (broken open and destroyed) by phage enzymes,
and the new phages are released. Lysogenic phages are some-
times called temperate phages. By contrast, a lytic phage is
only capable of the lytic cycle, i.e., bacterial cells are lysed
and destroyed after immediate replication of the viral particle
and the new phages are released to find new hosts. Lytic
phages do not create a lysogen. Lytic phages are sometimes
called virulent phages.
Using recombinant DNA technologies, bacteriophage
DNA can be manipulated to result in the expression of
reporter genes in target, infected bacteria. Such methods have
the potential of being very useful in detection assays. The
lysogenic bacteriophage (DVI O infects and reproduces in the
pathogenic E. coli 0157:H7. There remains a need for the
large scale propagation of phages in non-pathogenic E. coli,
thereby avoiding the safety and security risks of propagation
in the pathogenic E. coli 0157:H7. As contemplated herein,
such large scale propagation of phages may enable the cre-
ation of anti-bacterial polymers for applications such as pack-
aging materials for food or implantable medical devices. In
addition, contemplated herein are methods for detection of E.
coli in samples using bacteriophage immobilized on polymer
film, thereby avoiding the traditional need of various reagents
for detection.
BRIEF SUMMARY OF THE DISCLOSURE
Provided are compositions and methods for the generation
of reporter phage via genetic manipulation of lysogenic
2
(DV I O for targeted detection of viable E. coli 0157:H7 cells.
In one embodiment, target bacteria are detected in a sample
after infection with phage manipulated to include a colori-
metric reporter.
5 Provided are compositions and methods for the propaga-
tion of E. coli 0157:H7-specific bacteriophage in non-patho-
genic E. coli. In certain embodiments, large scale propagation
of E. coli 0157:H7-specific bacteriophage occurs from
lysogenic or lyric cycles in non-pathogenic E. coli.
10 Provided are compositions and methods for immobilizing
active bacteriophages on a polymer surface. In one embodi-
ment, UV polymerization is used for immobilization of phage
on a polymer surface.
Provided are compositions and methods for E. coli 0157:
15 H7 detection using bacteriophage immobilized on a polymer
film. In one embodiment, reporter-containing phage immo-
bilized on a polymer is contacted with a target bacteria-
containing sample, resulting in expression of the reporter and
detection of the target bacteria.
20
BRIEF DESCRIPTION OF THE DRAWINGS
FIG.1 schematically illustrates one embodiment of a bac-
teriophage assay.
25	 FIG. 2 schematically illustrates the UV polymerization
process for the production of film-embedded bacteriophages.
FIG. 3 shows images ofpetri dishes incubated with top agar
overlay containing E. coli cells, one petri dish having a cou-
pon with immobilized phage.
30	 FIG. 4 schematically illustrates possible modifications to
the bacteriophage (DVIO.
DETAILED DESCRIPTION OF THE PREFERRED
EMBODIMENTS
35
Unless defined otherwise, all technical and scientific terms
used herein have the meaning commonly understood by a
person skilled in the art to which this invention belongs. The
following references provide one of skill with a general defi-
4o nition of many of the terms used in this invention: Singleton
et al., 1994, Dictionary Of Microbiology And Molecular
Biology, 2nd ed., John Wiley and Sons, NY; The Cambridge
Dictionary Of Science And Technology, 1988, Walker ed.,
Cambridge University Press, Cambridge, UK; The Glossary
45 Of Genetics, 1991, 5th ed., Riegeretal., eds., SpringerVerlag,
Berlin, Germany; and Hale and Markham, 1991, The Harper
Collins Dictionary Of Biology, Harper Perennial, N.Y. As
used herein, the following terms have the meanings ascribed
to them unless specified otherwise.
50 Generation of Colorimetric Reporter Phage via Genetic
Manipulation of Lysogenic (DVIO for Targeted Detection of
Viable E. coli 0157:H7 Cells
In one embodiment, provided is a colorimetric "reporter
phage" to specifically detect viable E. coli 0157:H7 in test
55 samples. FIG. 1 illustrates the following five steps of this
process: 1. Phage identification; 2. Insertion of a reporter; 3.
Phage attachment to target bacteria; 4. Infection; and 5. Tran-
scription of reporter. Ultimately, as also referenced in FIG. 1,
expression of the reporter gene allows for a colorimetric or
60 optical readout, thereby confirming detection. (DVIO, a
lysogenic phage specific to E. coli 0157:H7, has a completely
sequenced genome, which facilitates genetic manipulation
and conversion of 4)VI O to a reporter phage (see FIG. 1, step
1, phage identification). An E. coli 0157: H7 detection system
65 can be constructed using lysogenic phage because the proph-
age or phage genome allows for positive selection of recom-





acterization studies have demonstrated that the E. coli 0157	 be done by creating a plasmid or genomic insert in which an
antigen represents the targeting receptor for this (DV 10 phage 	 antisense RNA complementary to the ribosome binding site
and is a major determinant of its specificity. Acetylation of the	 of gene 40 is expressed from an inducible/repressible pro-
E. coli 0157 antigen by an enzyme encoded by a (DV10 gene	 moter, such as araC-Para, lacl q-Plac, or X1857-PL.
abolishes the ability of (DV10 to infect an otherwise suscep- 5	 Induction or depression of the anti-sense RNA can trigger
tible host.	 the lytic cycle in the lysogens, yielding a full burst of phage
The phage uses this surface 0157 antigen to specifically	 from each cell in the culture. Alternatively, the role of the
target and identify a wide range of 01 57: H7 strains (see FIG. 	 anti-sense RNA could be played by an anti-repressor gene,
1, step 3, phage attachment to target bacteria), including 	 analogous to Xcro, if such a gene can be identified in (DV10.
C7927, EDL933, 204P, and ATCC 43895 (a variant which io Because the lysis genes will have been deleted from reporter
constitutively produces curli fibers on its surface that could 	 phage, the lysis genes will have to be expressed from the
potentially block attachment and infectivity by (DV10 but 	 inducible promoter as well.
does not). This broad host infectivity is important because an 	 In some embodiments, E. coli Top10: (DV10kan can be
ideal diagnostic assay should be able to detect all possible 	 modified to allow synthesis of phage which are capable of
pathogenic strains of contaminating E. coli 0157:H7 in both 15 lytic propagation only. Such phage are suitable for use in
food and environmental testing samples. 	 phage therapy or creation of antibacterial polymers as
Complete sequencing of the (DV10 phage genome has	 detailed below. The repressor gene (gene 40) can be intro-
identified recET, a putative non-essential gene, as an ideal
	
duced into the lysogen on a plasmid or genomic insertional
target for gene replacement experiments. The X-RED-based 	 unit under the control of an inducible/repressible promoter,
recombination system developed by Datsenko and Wanner 20 such as Para or Plac. The phage genomic copy of gene 40 is
was employed for the recET replacement procedure on the 	 then deleted. Lysogeny will be maintained as long as gene 40
lysogenized (DV10 phage (see FIG. 1, step 2, insertion of 	 is induced, but repression of gene 40 will trigger entry into the
cobA or lux reporter). In order to gain a preliminary under- 	 lytic cycle, releasing a burst of progeny phage from each cell.
standing of the replacement process, the inventors generated 	 The progeny phage, lacking the repressor gene, will be able to
two constructs, one with a kanamycin resistance gene and one 25 propagate lytically, but will not form lysogens. This is impor-
with both kanamycin resistance and cobA genes.	 tant because lysogens become immune to killing by the
Characterization of the former construct, designated (D V 10 	 phage. Deletion of gene 40 can be accomplished by first using
kanl, demonstrated the feasibility of this replacement strat- 	 homologous recombination to replace gene 40 with an anti-
egy and provided a control. For this diagnostic tool to be	 biotic resistance gene flanked by FLP recombinase recogni-
functional in real pathogen detection scenarios, it is required 30 tion sites, then using FLP recombinase to delete the antibiotic
that the modified "reporter" phage continues to retain its 	 resistance gene.
specific bacterial targeting and infectivity capability. Follow- 	 Method for Immobilizing Active Bacteriophages on a
ing replacement, the inventors harvested viable phage from a 	 Polymer Surface
culture of modified 4)V10 lysogens and demonstrated potent 	 Provided are compositions and methods that allow active
and specific E. coli 0157:H7 cell infectivity (see FIG. 1, steps 35 bacteriophages to get attached to the surface of a polymer in
3 and 4, phage attachment to target bacteria and infection). 	 order to kill target bacteria with which they come into contact.
Interestingly, (DV 10 kanl plaques were very turbid compared 	 In an embodiment, a support polymer is corona treated to
to the wild type, to the extent that they can be rather difficult 	 obtain a surface tension of greater than 45 dyne/cm. A mix-
to see and enumerate. Without being bound by the following 	 ture of trimethylolpropane triacrylate monomer, the photo-
theory, it is possible that the (DV10 kanl plaques are very 40 initiator methyl benzoylformate (2% wt/wt), and freeze-dried
turbid because they have a high propensity to make lysogens, 	 bacteriophage is applied to the support polymer surface and
which may end up being more useful to this strategy, as 	 polymerized using a UV cross-linker to form a film contain-
lysogens are not killed by infection.	 ing embedded bacteriophage. The intensity of UV light used
Propagation of E. coli 01 57:H7-Specific Bacteriophage in 	 is approximately 3400 µW/cm 2 with a cure time ranging
Non-Pathogens	 45 between 1-2 minutes under nitrogen atmosphere.
Provided are compositions and methods that allow bacte- 	 FIG. 2 schematically illustrates the following steps of the
riophages used for specific detection or killing of E. coli	 UV polymerization process for the production of film-em-
0157:H7 to be propagated on a large scale in non-pathogenic 	 bedded bacteriophages: corona treatment, oligomer and
E. coli, thereby eliminating the safety and security risks of	 active element application, and UV light exposure. The time
propagation in pathogenic E. coli 0157:H7.	 5o required for polymerization depends on several factors
The lysogenic bacteriophage (DV10 normally only infects 	 including the type of UV lamp used, the intensity of light and
E. coli O157:H7. However, as described herein, the (DV10 	 the photoinitiator. Incorporating the bacteriophage in the cure
lysogen of the non-pathogenic E. coli Top10 strain was iso-	 mixture and subjecting to UV polymerization embeds the
lated after introducing naked (DV10 DNA into Top 10 by	 active element in the cured polymer matrix.
transformation. The 4)V10 DNA that was used to make the 55 In one example, T4 bacteriophage were immobilized on a
lysogen (E. coli Top 10: (DV l Okan) had been previously modi-	 low density polyethylene coupon using the described proce-
fied by replacing the recET gene with a kanamycin resistance 	 dure:
gene, which permitted the lysogen to be isolated by positive 	 Immobilization Efficiency: The coupon with immobilized
selection for kanamycin resistance. Similar lysogens can be 	 phage was washed with sterile water for 1 minute and phage
isolated by transforming E. coli Top10 with DNA from 60 in the wash were enumeratedby plaque assay. It was observed
reporter phage constructed as described below for the detec- 	 that there was minimal loss of phage upon the first wash but
tion using bacteriophage immobilized in a polymer film. E.	 there was no plaque forming units in the subsequent washes.
coli Top10:(DV10kan does not spontaneously release active 	 This indicates that the immobilization is very effective and
(DV10 phage, probably because it is a recA mutant. Reporter	 the first wash is sufficient in eliminating all the unbound
phage can be synthesized and released from Top 10 lysogens 65 phage (if any).
by manipulating the expression of the repressor, GP40, which 	 Activity of the immobilized phage: The activity of the
is shown to be capable of repressing the lytic cycle. This can 	 immobilized phage against live E. coli cells in their log phase
US 8,114,622 B2
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was tested by placing a coupon with immobilized phage onto
the surface of a solid growth medium, then overlaying with
molten top agar containing 100 ld E. coli cells/3 ml. No
bacterial growth occurred in the vicinity of the coupon, indi-
cating that immobilized phage are active and able to infect
host bacteria.
FIG. 3 shows images of the petri dishes incubated with top
agar overlay containing E. coli cells. A coupon with immo-
bilized T4 phage was included in the dish on the left. As
described above, and in contrast to the petri dish on the right,
no bacterial growth occurred in the area covered by the cou-
pon. A control coupon coated with a film that lacked immo-
bilized phage had no visible effect on bacterial growth (data
not shown).
E. coli 0157:117 Detection using Bacteriophage Immobi-
lized on a Polymer Film
Provided are modified bacteriophages immobilized to a
surface, which capture E. coli 0157:117 and cause the cap-
tured cells to emit light or fluorescence, thereby allowing
detection.
As described above, (DV10 phage, a lysogenic phage spe-
cific for E. coli 0157:117, can be modified by replacement of
the non-essential gene recET with a cassette including a kana-
mycin resistance gene (to enable positive selection of recom-
binants) and a reporter gene or gene cluster such as the red
fluorescent reporter cobA or the bioluminescent reporter lux-
CDABE. Gene replacement can be carried out in an E. coli
0 157:1 7 strain lysogenic for (DV10 and can be accomplished
by homologous recombination. It is necessary to remove
additional non-essential DNA in order to achieve packaging
of the luxCDABE modified phage. The phage lytic genes will
be removed in order to prevent lysis of infected cells. The
phage with this modification can be propagated as described
above. Antibiotic resistance genes can generally be removed
using the FLP recombinane once they have fulfilled their
purpose of allowing positive recombinant selection. FIG. 4
illustrates modifications that can be made to (DV10 phage.
In some examples, the recET gene of a (DV10 lysogen has
been successfully replaced by a kanamycin resistance gene.
This lysogen spontaneously releases active bacteriophages
that are capable of infecting E. coli 0 157:1 7, undergoing the
lytic cycle, and forming lysogens. Lysogens containing the
modified bacteriophage are resistant to kanamycin. The loca-
tion of the kanamycin resistance gene in the position formerly
occupied by recET has been confirmed by PCR.
In an embodiment, modified bacteriophage is immobilized
to a discreet patch of a stomacher bag inner surface using the
methods for immobilizing active bacteriophages to a polymer
surface, as described above. For detection of E. coli 0157:117,
a food sample can be mixed with a standard enrichment broth
in a stomacher bag containing the immobilized reporter
phage. If E. coli 0 157:1 7 are present, they will multiply in the
enrichment broth and will also be captured and infected by the
immobilized phage. Infection results in irreversible attach-
ment of the bacterial cell to the immobilized phage, and also
expression of the reporter genes. In turn, bioluminescence or
red fluorescence appears on the stomacher bag surface where
the phage are immobilized. Enrichment, capture, and detec-
tion are thereby accomplished simultaneously.
6
It is to be understood that this invention is not limited to the
particular devices, methodology, protocols, subjects, or
reagents described, and as such may vary. It is also to be
understood that the terminology used herein is for the purpose
5 of describing particular embodiments only, and is not
intended to limit the scope of the present invention, which is
limited only by the claims. Other suitable modifications and
adaptations of a variety of conditions and parameters, obvi-
ous to those skilled in the art, are within the scope of this
invention. All publications and patent applications cited10 herein are incorporated by reference in their entirety for all
purposes.
What is claimed is:
1.A method of detecting the presence of a target bacterium
in a sample, the method comprising:
15	 identifying a lysogenic phage specific to the target bacte-
rium;
inserting a polynucleotide encoding a reporter polypeptide
into the phage,
the reporter polypeptide being red fluorescent reporter
20	 cobA;
contacting the phage with a preparation derived from the
sample; and
observing the expression or lack of expression of the
reporter polypeptide, thereby detecting the presence or
25	 absence of the target bacterium in the sample.
2. The method of claim 1 wherein the expression of the
reporter polypeptide is detected colorimetrically or optically.
3. The method of claim 1 wherein the target bacterium is E.
coli 0157:117.
30 4. The method of claim 1 wherein the lysogenic phage is
4)V10.
5. The method of claim 4 wherein the recET gene of (DV 10
is replaced with the reporter polypeptide.
6.A method of detecting the presence of a target bacterium
35 in a sample, the method comprising:
providing a lysogenic phage specific to the target bacte-
rium, wherein the lysogenic phage is immobilized on a
polymer surface, and wherein the lysogenic phage com-
prises a polynucleotide encoding a reporter polypeptide,
40	 the reporter polypeptide being red fluorescent reporter
cobA;
contacting the lysogenic phage with a preparation derived
from the sample; and
observing the expression or lack of expression of the
45	 reporter polypeptide, thereby detecting the presence or
absence of the target bacterium in the sample.
7. The method of claim 6 wherein the expression of the
reporter polypeptide is detected colorimetrically or optically.
8. The method of claim 6 wherein the target bacterium is E.
50 coli O15:1 7.
9. The method of claim 6 wherein the lysogenic phage is
4)V10.
10. The method of claim 9 wherein the recET gene of
(DV 10 is replaced with the reporter polypeptide.
55 11. The method of claim 6 wherein the sample is taken
from food or beverage.
12. A kit comprising instructions and materials for carrying
out the method of claim 6, including a polymer surface having
a reporter polynucleotide-containing phage attached thereto.
